Your browser doesn't support javascript.
loading
Time-series analysis in imatinib-resistant chronic myeloid leukemia K562-cells under different drug treatments.
Zhao, Yan-Hong; Zhang, Xue-Fang; Zhao, Yan-Qiu; Bai, Fan; Qin, Fan; Sun, Jing; Dong, Ying.
Afiliación
  • Zhao YH; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China. zhyanred@163.com.
  • Zhang XF; Department of Hematology, the Second Affiliated Hospital, Qiqihaer Medical College, Qiqihaer, 161006, China.
  • Zhao YQ; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.
  • Bai F; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.
  • Qin F; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.
  • Sun J; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.
  • Dong Y; Department of Hematology, the First Affiliated Hospital, Harbin Medical University, Harbin, 150001, China.
J Huazhong Univ Sci Technolog Med Sci ; 37(4): 621-627, 2017 Aug.
Article en En | MEDLINE | ID: mdl-28786057
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Huazhong Univ Sci Technolog Med Sci Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: China
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Leucemia Mielógena Crónica BCR-ABL Positiva / Mesilato de Imatinib Tipo de estudio: Prognostic_studies Límite: Humans Idioma: En Revista: J Huazhong Univ Sci Technolog Med Sci Asunto de la revista: MEDICINA Año: 2017 Tipo del documento: Article País de afiliación: China